2022 Guidance and E.S.G. Considerations

Hospice Quality: Amedisys Hospice Continues to Move Towards Best-in-Class Hospice Item Set (HIS) Preview - Feb 2022 Jul 2020 - Mar 2021 Discharges 100.0% 99.5% 99.7% 100.0% 100.0% 97.9% 97.7% 99.4% 93.6% 99.8% 98.9% 99.4% 99.9% 99.0% 97.3% 94.3% 92.8% 95.0% 90.0% 90.0% 82.6% 85.0% 80.0% 75.0% 70.0% 65.0% Treatment Preferences Beliefs / Values Addressed Pain Screening Pain Assessment Dyspnea Screening Dyspnea Treatment Patient Treated with an Opioid Who Are Given a Bowel Regimen * Hospice Visits When Death Is Imminent, Measure 1 Hospice and Palliative Care Composite Process Measure 95.0% 90.0% 85.0% 81.8% 81.0% 80.0% 78.3% 78.0% AMED CMS Nat Hospice CAHPS Preview - Feb 2022 Oct 2018 - Dec 2019; July 2020 - March 2021 Discharges 90.5% 91.0% 90.0% 90.0% 77.9% 76.2% 76.0% 75.0% 84.5% 84.0% 82.6% 82.0% 81.2% 81.0% 75.0% 70.0% 65.0% Communication Timely Care Treat with Respect Emo / Rel Support Help For Symptoms Hospice Training Rating of Hospice Care Willingness to Recommend CAHPS Roll-Up / Average AMED CMS Nat Notes: Included in the above analysis are active care centers. Acquired locations were only included if their acquisition date was before the start of the reporting window. Above excludes Asana, Aseracare, and CCH acquisitions. * Hospice Visits When Death is Imminent, Measure 1 is referencing discharges from Jan 2019 through Dec 2019 12

View entire presentation